Clinical Trial Update: Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMO [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adding cangrelor to standard anticoagulation in patients with myocardial infarction-related cardiogenic shock or cardiac arrest support…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrest
• Cardiogenic Shock
• Myocardial Infarction

Drugs mentioned

• Cangrelor (cangrelor)

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Cardiogenic Shock, Extracorporeal Membrane Oxygenation Complication | Phase 2 | Status: RECRUITING